Enhancing drug discovery using advanced techniques for detecting weak binding molecules
Improving Fragment Based Drug Discovery and the Development of Tools for Chemical Biology through Nanoscale Encapsulation and NMR Spectroscopy
This study is working on finding better ways to discover new drugs by using advanced techniques to spot tiny molecules that stick to proteins, which could help create more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m Agrilife Research NIH-funded |
| Lab location | 1 site (College Station, UNITED STATES) |
| Project ID | NIH-10911303 on NIH RePORTER |
What this research studies
This research focuses on improving the process of drug discovery by developing new methods to detect weakly binding molecules that are often overlooked. By utilizing nanoscale encapsulation and NMR spectroscopy, the study aims to create a more efficient way to identify and quantify the binding of small molecules to proteins. This approach seeks to address the limitations of traditional high-throughput screening methods, which can be costly and inefficient. Patients may benefit from this research as it could lead to the development of new and more effective drugs for various conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be treated by new small molecule drugs targeting specific proteins.
Not a fit: Patients with conditions that do not involve the proteins targeted by this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new small molecule drugs that are more effective in treating diseases.
How similar studies have performed: Previous research has shown promise in improving drug discovery techniques, but this specific approach using nanoscale encapsulation and NMR spectroscopy is relatively novel.
Where this research is happening
College Station, UNITED STATES
- Texas A&m Agrilife Research — College Station, United States (Active)
Researchers
- Principal investigator: Wand, a. Joshua — Texas A&m Agrilife Research
- Study coordinator: Wand, a. Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.